ANO1 and endothelial dysfunction: Ma et al. developed two animal models of transgenic mice: TMEM16A−/− and TMEM16A-overexpressed targeted to the endothelium, showing a significant decrease in blood pressure and an improvement in endothelial dysfunction in TMEM16A−/− mice.